Heterogeneity of interleukin 5 genetic background in atopic dermatitis patients: Significant difference between those with blood eosinophilia and normal eosinophil levels

Journal of Dermatological Science

Volumn 33, Issue 2, 2003, Pages 121-126

  Yamamoto, N ^a   Sugiura, H ^a   Tanaka, K ^a   Uehara, M ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Atopic dermatitis; Eosinophil; Gene; Interleukin 5; Polymorphism

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 5;

ADOLESCENT; ADULT; AGED; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DNA POLYMORPHISM; EOSINOPHIL; EOSINOPHILIA; FEMALE; GENE FUNCTION; GENOTYPE; HUMAN; IMMUNOGLOBULIN PRODUCTION; MALE; PATIENT CODING; PRIORITY JOURNAL;

EID: 0142152268     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-1811(03)00149-X     Document Type: Article

References (28)

1. Warren D.J., Moore M.A. Synergism among interleukin 1, interleukin 3, and interleukin 5 in the production of eosinophils from primitive hemopoietic stem cells. J. Immunol. 140:1988;94-99.
2. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167:1988;1737-1742.
3. Kita H., Weiler D.A., Abu-Ghazaleh R., Sanderson C.J., Gleich G.J. Release of granule proteins from eosinophils cultured with IL-5. J. Immunol. 149:1992;629-635.
4. Rioux J.D., Stone V.A., Daly M.J., Cargill M., Green T., Nguyen H., et al. Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am. J. Hum. Genet. 63:1998;1086-1094.
5. Sulzberger M.B. Atopic dermatitis: its clinical and histologic picture. Baer R.L. Atopic dermatitis. 1955;11-42 New York University Press, Philadelphia.
6. Rajka G. Atopic dermatitis. 1975;42-45 WB Saunders, London.
7. Uehara M., Izukura R., Sawai T. Blood eosinophilia in atopic dermatitis. Clin. Exp. Dermatol. 15:1990;264-266.
8. Rajka G. Prurigo Besnier (atopic dermatitis) with special reference to the role of allergic factors. I. The influence of atopic hereditary factors. Acta Dermatol. Venereol. 40:1960;285-306.
9. Uehara M., Sawai T. Familial background of respiratory atopy - a factor of type I allergy to house dust mite in patients with atopic dermatitis. Arch. Dermatol. 125:1989;939-943.
10. Schults Larsen F. Genetic aspects of atopic eczema. Ruzicka T., Ring J., Przybilla B. Handbook of atopic eczema. 1991;15-26 Springer, Berlin.
11. Hill L.W., Sulzberger M.B. Evolution of atopic dermatitis. Arch. Dermatol. 32:1935;451-463.
12. Tanaka K., Sugiura H., Uehara M., Hashimoto Y., Donnelly C., Montgomery D.S. Lack of association between atopic eczema and the genetic variants of interleukin-4 and the interleukin-4 receptor α chain gene: heterogeneity of genetic backgrounds on immunogloblin E production in atopic eczema patients. Clin. Exp. Allergy. 31:2001;1522-1527.
13. Uehara M. Heterogeneity of serum IgE levels in atopic dermatitis. Acta Dermatol. Venereol. (Stockh.). 66:1986;404-408.
14. Wüthrich B. Atopic neurodermatitis. Wien. Med. Wochenschr. 139:(6-7):1989;156-165.
15. Akdis C.A., Akdis M., Simon D., Dibbert B., Weber M., Gratzl S., et al. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J. Invest. Dermatol. 113:(4):1999;628-634.
16. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Dermatol. Venereol. (Stockh.). 92:(Suppl):1980;44-47.
17. Kondo S., Yazawa H., Jimbow K. Reduction of serum interleukin-5 levels reflect clinical improvement in patients with atopic dermatitis. J. Dermatol. 28:(5):2001;237-243.
18. Tanaka K., Sugiura H., Uehara M., Sato H., Hashimoto-Tamaoki T., Furuyama J. Association between mast cell chymase genotype and atopic eczema: comparison between patients with atopic eczema alone and those with atopic eczema and atopic respiratory disease. Clin. Exp. Allergy. 29:1999;800-803.
19. Wüthrich B. Serum IgE in atopic dermatitis: relationship to severity of cutaneous involvement and course of disease as well as coexistence of atopic respiratory disease. Clin. Allergy. 8:1978;241-248.
20. Gulbenkian A.R., Egan R.W., Fernandez X., Jones H., Kreutner W., Kung T., et al. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung. Am. Rev. Respir. Dis. 146:1992;263-266.
21. Chand N., Harrison J.E., Rooney S., Pillar J., Jakubicki R., Nolan K., et al. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach. Eur. J. Pharmacol. 211:(1):1992;121-123.
22. Mauser P.J., Pitman A., Witt A., Fernandez X., Zurcher J., Kung T., et al. Inhibitory effect of the TRFK-5 anti-IL-5 antibody in a guinea pig model of asthma. Am. Rev. Respir. Dis. 148:(6 Pt 1):1993;1623-1627.
23. Kapp A. The role of eosinophils in the pathogenesis of atopic dermatitis - eosinophil granule protein as markers of disease activity. Allergy. 48:(1):1993;1-5.
24. Tsuda S., Kato K., Miyasato M., Sasai Y. Eosinophil involvement in atopic dermatitis as reflected by elevated serum levels of eosinophil cationic protein. J. Dermatol. 19:(4):1992;208-213.
25. Spencer C.M., Faulds D., Peters D.H. Cetirizine. A reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs. 46:(6):1993;1055-1080.
26. Omoto M., Gu L.H., Sugiura H., Uehara M. Heterogeneity of dermal deposition of eosinophil granule major basic protein in acute lesions of atopic dermatitis. Arch. Dermatol. Res. 292:2000;51-54.
27. Stranick K.S., Zambas D.N., Uss A.S., Egan R.W., Billah M.M., Umland S.P. Identification of transcription factor binding sites important in the regulation of the human interleukin-5 gene. J. Biol. Chem. 272:(26):1997;16453- 16465.
28. Mori A., Kaminuma O., Ogawa K., Okudaira H., Akiyama K. Transcriptional regulation of IL-5 gene by nontransformed human T cells through the proximal promoter element. Intern. Med. 39:(8):2000;618-625.